Cozaar News
Merck reports big loss due to Vioxx charges - MarketWatch
Older hypertension medicines Cozaar and Hyzaar saw sales rise 3% to $891 million. Merck's newer vaccines fared well. Sales of Gardasil climbed to $339 ...
Merck reports loss due to Vioxx charges - MarketWatch
Older hypertension medicines Cozaar and Hyzaar saw sales rise 3% to $891 million. Another best-selling product, the osteoporosis drug Fosamax, ...
Merck still a buy at Citigroup, Merrill Lynch ahead of 4Q report - Euro2day
Patents for Fosamax and Cozaar/Hyzaar expire next month and in 2010, respectively. Risinger dropped per-share earnings estimate for 2008 to $3.21 from $3.38 ...
Merck still a buy at Citigroup, Merrill Lynch ahead of 4Q report - Euro2day
Patents for Fosamax and Cozaar/Hyzaar expire next month and in 2010, respectively. Risinger dropped per-share earnings estimate for 2008 to $3.21 from $3.38 ...
Merck & Co., Inc. Q4 2007 Earnings Call Transcript - Seeking Alpha
Our most established products also continue to deliver strong performances, including SINGULAIR, COZAAR, HYZAAR, ZETIA, and VYTORIN. ...
Merck posts $1.6 billion Q4 loss due to Vioxx deal, other charges - Press of Atlantic City
Sales jumped 20 percent for Singulair, to $1.15 billion, and rose 3 percent, to $891 million, for related blood pressure drugs Cozaar and Hyzaar. ...
EI du Pont de Nemours & Co. Q4 2007 Earnings Call Transcript - Seeking Alpha
While weaker dollar at Cozaar certainly helped, they were not the primary reason we overcame the challenging environment in US housing, ...
EI du Pont de Nemours & Co. Q4 2007 Earnings Call Transcript - Seeking Alpha
While weaker dollar at Cozaar certainly helped, they were not the primary reason we overcame the challenging environment in US housing, ...
Drug industry failing to replace fading hits - Arkansas Democrat Gazette
... face generic competition to its three top-selling drugs: the osteoporosis treatment Fosamax, Singulair for asthma and the blood-pressure drug Cozaar. ...
Globes, Tel Aviv, Israel, Gitit Pincas column: Teva's horizon - Trading Markets (press release)
... with generic launches of drugs such as the anti depressant Effexor (estimated sales of $445 million), the hypertension drug Hyzaar/Cozaar (estimated ...
Cozaar RSS Feed